Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?

Peiró, Concepción; Moncada, Salvador

Peiró, Concepción; Moncada, Salvador.

Affiliation

Peiró C; Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Spain (C.P.).
Moncada S; Instituto de Investigaciones Sanitarias IdiPAZ, Madrid, Spain (C.P.).

Circulation ; 141(21): 1665-1666, 2020 05 26.

Article in En | MEDLINE | ID: mdl-32242749

Subject(s)

Angiotensin I/physiology; Betacoronavirus; Coronavirus Infections/prevention & control; Lung Injury/prevention & control; Pandemics/prevention & control; Peptide Fragments/physiology; Pneumonia, Viral/prevention & control; Angiotensin-Converting Enzyme 2; COVID-19; Humans; Lung/virology; Peptidyl-Dipeptidase A/physiology; SARS-CoV-2

Key words

angiotensin receptor blockers; angiotensins; ards, human; lung inflammation; sars coronavirus; treatment; vascular endothelial cells

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Pneumonia, Viral / Angiotensin I / Coronavirus Infections / Lung Injury / Pandemics / Betacoronavirus Limits: Humans Language: En Journal: Circulation Year: 2020 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google